T1	Disease	85 108	adenocarcinoma patients
T2	Limited_variation	131 155	EGFR mutation status and
T3	Chemical	205 237	platinum doublet chemotherapy in
T4	Phenotype	274 325	clinical outcomes and recurrence patterns according
T5	Limited_variation	329 346	mutation status .
R1	isAssociatedWith	Arg1:T1	Arg2:T2
R2	isAssociatedWith	Arg1:T1	Arg2:T3
R3	isAssociatedWith	Arg1:T1	Arg2:T4
R4	isAssociatedWith	Arg1:T1	Arg2:T5
R5	isAssociatedWith	Arg1:T2	Arg2:T1
R6	isAssociatedWith	Arg1:T2	Arg2:T3
R7	isAssociatedWith	Arg1:T2	Arg2:T4
R8	isAssociatedWith	Arg1:T2	Arg2:T5
R9	treats	Arg1:T3	Arg2:T1
R10	isAssociatedWith	Arg1:T3	Arg2:T4
R11	isAssociatedWith	Arg1:T3	Arg2:T5
R12	isAssociatedWith	Arg1:T4	Arg2:T1
R13	isAssociatedWith	Arg1:T4	Arg2:T2
R14	isAssociatedWith	Arg1:T4	Arg2:T3
R15	isAssociatedWith	Arg1:T4	Arg2:T5
R16	influences	Arg1:T5	Arg2:T1
R17	isAssociatedWith	Arg1:T5	Arg2:T2
R18	influences	Arg1:T5	Arg2:T3
R19	isAssociatedWith	Arg1:T5	Arg2:T4
